How certain FODMAPs affect IBS pain in adults
Official title: The Role of Gut Microbiota in Patient Responses to a Dietary Therapy for Abdominal Pain
Run by Queen's University · NCT07688044 · Data updated 2026-11-12
This study tests whether adding back specific FODMAP types after a low-FODMAP diet can reveal which ones drive abdominal pain in adults with IBS.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Queen's University Academic / other |
| Locations | 1 site (Kingston, Ontario) |
| Status | Recruiting |
| Started | March 16, 2026 |
| Main results expected | March 2030 |
| Study ends | March 2031 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT07688044 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-70 with IBS who have a PROMIS belly pain score greater than 12 and meet Rome IV/V criteria.
✕Probably not a fit
Patients who do not experience pain changes with FODMAP subtype reintroduction or who do not adhere to the dietary protocol may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with IBS follow a low-FODMAP diet and then subtypes of FODMAPs are reintroduced to see which ones increase pain, while stool samples help explore gut bacteria and other mediators. The study aims to separate the roles of diet and the microbiome in IBS pain signaling. Participants are monitored for changes in belly pain and related symptoms during the reintroduction phase. The trial will help identify targeted dietary strategies for reducing pain in IBS patients. It is conducted at Hotel Dieu Hospital in Kingston with sponsorship from the Weston Family Foundation and led by investigator David Reed.
Why it matters
Potential benefit: If successful, the findings could guide more precise dietary guidance to reduce IBS-related abdominal pain.
How similar studies have gone: Previous work shows that restricting FODMAPs can relieve IBS pain in many patients, supporting the potential value of subtype testing in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18-70 with IBS (Rome IV (now V) criteria) * PROMIS belly pain score \>12 Exclusion Criteria: 1. Concurrent significant organic GI pathology (i.e. celiac, IBD, etc.) as some symptoms may be related to their disease and not IBS. 2. Concurrent systemic disease and/or laboratory abnormalities considered by investigators to be risky or that could interfere with data collection. 3. Major gastrointestinal surgery (e.g. Roux en y, bowel resection) as symptoms may be related to previous surgery rather than IBS. 4. Body mass index above 35 kg/m2 as it is unknown how mediators in the GI tract that may be involved in pain signaling in the gut are affected by obesity. 5. History of active cancer in the last 5 years, other than basal cell cancer as the treatment may have impacted the GI tract. 6. Pregnant or breastfeeding women. 7. Active or recent participation (\< 1 month) in a clinical study. 8. Use of antibiotics, probiotics, during, or one month prior to the study as may affect gut microbiota. 9. Use of new medications less than 4 weeks prior to the study as may alter gut microbiota and/or IBS symptoms. 10. Allergies to any of the ingredients used in the study. 11. Any immune-compromising conditions as may affect GI symptoms. 12. Currently being treated for eating disorder, schizophrenia, psychosis or other acute mental disorders as participating in a diet challenge study may have negative impact on these disorders.
Where it's running
-
Hotel Dieu Hospital
Kingston, Ontario, Canada Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Vitamin D Supplementation in Children with Irritable Bowel Syndrome
This study tests whether giving vitamin D to children with IBS and low vitamin D levels can improve their IBS symptoms compared with a placebo.
-
IBS-oriented Crohn's Disease Exclusion Diet versus Low FODMAP Diet for IBS
This study tests whether an IBS-adapted Crohn's Disease Exclusion Diet (CDED) can better help adults with IBS-D or IBS-M than the low FODMAP diet.
-
Gut–brain gut study in IBS with anxiety and depression
This study will compare people with IBS and mood symptoms to healthy volunteers to see if gut bacteria relate to brain function using questionnaires, stool and blood samples, and a brain MRI.
-
Pregabalin for irritable bowel syndrome in adults
A clinician-led study will test whether pregabalin helps adults with irritable bowel syndrome who meet specific symptom criteria.
-
Probiotic combination for irritable bowel syndrome
This trial will test whether a daily probiotic capsule lowers symptom severity and affects gut transit time in adults with IBS.
-
Lyophilized donor gut bacteria capsules for treating irritable bowel syndrome
This trial will test whether taking oral freeze-dried fecal microbiota capsules can help adults 18–65 with IBS that hasn't responded to usual treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.